Shalamar Sibley

Shalamar Sibley serves as an Associate Professor at the University of Minnesota School of Medicine, holding dual appointments in the Department of Medicine, Endocrine and Diabetes Division and the Healthy Weight Research Center. Her clinical work is anchored at the Minneapolis Veterans Affairs Medical Center, where she integrates endocrine care with veteran-specific health initiatives.

Dr. Sibley's research spans diabetes complications, obesity pharmacotherapy, and nutrition-cancer interactions, with emphasis on vulnerable populations like veterans. Her fingerprint analysis highlights expertise in Type 1 Diabetes Mellitus (100%), Diabetes Complications (97%), and Weight Loss (72%), reflecting a clinical-research continuum focused on metabolic health outcomes. Recent work explores telehealth adaptations for obesity care during the pandemic and molecular mechanisms in malignancy-related endocrine disorders.

Key funded projects include:

• Nutrition as Prevention for Improved Cancer Outcomes (AHRQ, 2021-2022): A systematic review examining dietary interventions for cancer prevention
• Exenatide Treatment Pilot Study (AstraZeneca, 2015-2019): Investigating GLP-1 agonists for hypoglycemia management

These grants demonstrate translational focus from pharmacotherapy to population health.

Collaborative networks extend across oncology, endocrinology, and veterans' health services, with notable partnerships at the Minneapolis VA facility. Her work actively contributes to UN Sustainable Development Goals through diabetes prevention and nutritional oncology initiatives.